Works matching Cyclin-dependent kinase inhibitors
Results: 4517
SKUAMÖZ HÜCRELİ LARİNKS KANSERİNDE p53 MUTASYONU VE p21 SİKLİN BAĞIMLI KİNAZ İNHİBİTÖRÜ EKSPRESYONUNUN SAĞKAUM VE PROGNOSTİK FAKTÖRLERLE İLİŞKİSİ.
- Published in:
- Nobel Medicus Journal, 2014, v. 10, n. 1, p. 68
- By:
- Publication type:
- Article
Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 9, p. 1463, doi. 10.1002/cncr.29213
- By:
- Publication type:
- Article
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 8, p. 739, doi. 10.1159/000509865
- By:
- Publication type:
- Article
Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma.
- Published in:
- Molecular Genetics & Genomic Medicine, 2022, v. 10, n. 12, p. 1, doi. 10.1002/mgg3.2074
- By:
- Publication type:
- Article
Hypoxia Promotes Vascular Smooth Muscle Cell Proliferation through microRNA-Mediated Suppression of Cyclin-Dependent Kinase Inhibitors.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 8, p. 802, doi. 10.3390/cells8080802
- By:
- Publication type:
- Article
A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 5025, doi. 10.2147/OTT.S196607
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 2, p. 245, doi. 10.1007/s10238-022-00814-3
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.
- Published in:
- Journal of Korean Neurosurgical Society, 2023, v. 66, n. 6, p. 662, doi. 10.3340/jkns.2023.0005
- By:
- Publication type:
- Article
RAZLIKA IZMEĐU NUSPOJAVA INHIBITORA O CIKLINIMA OVISNIH KINAZA 4/6: ISKUSTVA I PREPORUKE ZA SVAKODNEVNU KLINIČKU PRAKSU.
- Published in:
- Lijecnicki Vjesnik, 2024, v. 146, p. 37, doi. 10.26800/LV-146-supl4-2
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors combined with stereotactic ablative radiotherapy in oligometastatic HR-positive/HER2-negative breast cancer patients.
- Published in:
- British Journal of Radiology, 2024, v. 97, n. 1162, p. 1627, doi. 10.1093/bjr/tqae138
- By:
- Publication type:
- Article
Arthralgia induced by endocrine therapy with or without cyclin‐dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta‐analysis.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e175, doi. 10.1111/ajco.13840
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase Inhibitor p21<sup>WAF1/CIP1</sup> Facilitates the Development of Cardiac Hypertrophy.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 4, p. 1645, doi. 10.1159/000479407
- By:
- Publication type:
- Article
Decreased mitochondrial transcription factor A and mitochondrial DNA copy number promote cyclin-dependent kinase inhibitor 1A expression and reduce tumorigenic properties of colorectal cancer cells.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01538-4
- By:
- Publication type:
- Article
Sodium valproate affects the expression of p16<sup>INK4a</sup> and p21<sup>WAFI/Cip1</sup> cyclin‑dependent kinase inhibitors in HeLa cells.
- Published in:
- Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14563
- By:
- Publication type:
- Article
Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review).
- Published in:
- Oncology Letters, 2024, v. 27, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14278
- By:
- Publication type:
- Article
MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.
- Published in:
- Oncology Letters, 2017, v. 13, n. 2, p. 722, doi. 10.3892/ol.2016.5463
- By:
- Publication type:
- Article
Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1408664
- By:
- Publication type:
- Article
Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines.
- Published in:
- Journal of Biomedical Science, 2015, v. 22, n. 1, p. 1, doi. 10.1186/s12929-015-0163-x
- By:
- Publication type:
- Article
Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
- Published in:
- Oncology Research, 2017, v. 25, n. 5, p. 721, doi. 10.3727/096504016X14772375848616
- By:
- Publication type:
- Article
Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges.
- Published in:
- Expert Reviews in Molecular Medicine, 2021, v. 23, p. 1, doi. 10.1017/erm.2021.3
- By:
- Publication type:
- Article
Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2806, doi. 10.3390/ijms22062806
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase Inhibitors KRP1 and KRP2 Are Involved in Grain Filling and Seed Germination in Rice (Oryza sativa L.).
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 245, doi. 10.3390/ijms21010245
- By:
- Publication type:
- Article
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-29
- By:
- Publication type:
- Article
Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 7, p. 927, doi. 10.3390/ph17070927
- By:
- Publication type:
- Article
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 105, doi. 10.1007/s00280-015-2772-1
- By:
- Publication type:
- Article
Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 10, p. 557, doi. 10.1159/000518573
- By:
- Publication type:
- Article
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.643155
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-50
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 5, p. 464, doi. 10.3390/jpm14050464
- By:
- Publication type:
- Article
Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors.
- Published in:
- Molecular Medicine Reports, 2019, v. 19, n. 5, p. 3593
- By:
- Publication type:
- Article
Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
- Published in:
- Molecular Medicine Reports, 2016, v. 14, n. 2, p. 1523, doi. 10.3892/mmr.2016.5401
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 6, p. 652, doi. 10.1002/phar.1756
- By:
- Publication type:
- Article
Selective Cyclin-Dependent Kinase 4/6 Inhibitors as Anticancer Drugs: Moving beyond Hormone Receptor-Positive Breast Cancer.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2019, v. 40, n. 1, p. 15, doi. 10.4103/ijmpo.ijmpo_87_18
- By:
- Publication type:
- Article
IZBOR LIJEČENJA NAKON PROGRESIJE NA TERAPIJU INHIBITORIMA O CIKLINIMA OVISNIH KINAZA 4/6.
- Published in:
- Lijecnicki Vjesnik, 2024, v. 146, p. 36, doi. 10.26800/LV-146-supl4-2
- By:
- Publication type:
- Article
Metal complexes with heteroscorpionate ligand founded on the pyridinamine group: cyclin-dependent kinase 2 inhibitor antimicrobial, antioxidant, and in vitro cytotoxicity, notional studies.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 3349, doi. 10.31838/ijpr/2021.13.01.427
- By:
- Publication type:
- Article
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2353, doi. 10.3390/ijms20092353
- By:
- Publication type:
- Article
Cyclin-dependent kinase inhibitors in malignant hematopoiesis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.916682
- By:
- Publication type:
- Article
Evaluation of Cyclin-Dependent Kinase Inhibitor 2A and Hepatocyte Nuclear Factor-1A Gene Polymorphisms in Coronary Artery Diseases.
- Published in:
- Zagazig University Medical Journal, 2024, v. 30, n. 3, p. 859, doi. 10.21608/ZUMJ.2022.161460.2636
- By:
- Publication type:
- Article
Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 21, p. 1673, doi. 10.1093/jnci/djs373
- By:
- Publication type:
- Article
Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00055
- By:
- Publication type:
- Article
Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27<sup>kip1</sup> and p21<sup>waf1/cip1</sup> in the diagnosis of pulmonary neuroendocrine tumours.
- Published in:
- Histopathology, 2012, v. 60, n. 5, p. 731, doi. 10.1111/j.1365-2559.2011.04137.x
- By:
- Publication type:
- Article
The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1454844
- By:
- Publication type:
- Article
Relationship between the Contents of Cyclins, Cyclin-Dependent Kinases, and Their Inhibitors in Whole Blood Mononuclear Leukocytes during the Postclinical Stage of Community-Acquired Pneumonia under the Influence of 1-GHz Microwaves.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2017, v. 163, n. 5, p. 623, doi. 10.1007/s10517-017-3864-1
- By:
- Publication type:
- Article
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0873-5
- By:
- Publication type:
- Article
Vitiligo‐like lesions induced by cyclin‐dependent kinase 4/6 inhibitor palbociclib.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 2, p. e98, doi. 10.1111/ijd.16356
- By:
- Publication type:
- Article
Deletion of a cyclin-dependent protein kinase inhibitor, CsSMR1, leads to dwarf and determinate growth in cucumber (Cucumis sativus L.).
- Published in:
- Theoretical & Applied Genetics, 2022, v. 135, n. 3, p. 915, doi. 10.1007/s00122-021-04006-7
- By:
- Publication type:
- Article
Induction of Eosinophil Apoptosis by the Cyclin- Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025683
- By:
- Publication type:
- Article
The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors.
- Published in:
- Bratislava Medical Journal / Bratislavské Lekárske Listy, 2023, v. 124, n. 4, p. 261, doi. 10.4149/BLL_2023_039
- By:
- Publication type:
- Article
细胞周期蛋白依赖性激酶 7 抑制剂 THZ1 对脑胶质瘤干细胞干性的调控及机制.
- Published in:
- Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2025, v. 29, n. 25, p. 5374, doi. 10.12307/2025.528
- By:
- Publication type:
- Article